Showing 21 - 38 of 38 Results for "mortality rates"

Results

Treatment
Antiretroviral therapy has transformed HIV to a chronic - though still incurable - virus requiring ongoing therapy and strict adherence to treatment. For the most part, virally suppressed people living with HIV today have no difference in life expectancy than demographically similar HIV-negative individuals (Sabin, 2013 cited in Justice and Falutz, 2014; Maman et al. 2012a). This section does ...
Decentralization and integration of HIV services may increase adherence and early access to ART. [See also %{c:25}]
Adherence and Support
7 studies Gray I, IIIa Central African Republic, adherence, and Zimbabwe, health facilities, health services, the Democratic Republic of the Congo, the Republic of the Congo, treatment Cambodia, Côte d'Ivoire, Democratic Republic of Congo, Ethiopia, India, Kenya, Lesotho, Malawi, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Tanzania, Thailand, Uganda, Zambia
Tuberculosis
Preventing, Detecting and Treating Critical Co-Infections
Tuberculosis is the leading cause of death among people with HIV globally, accounting for almost 25% of all HIV deaths in 2008 (WHO, 2009i). The risk of acquiring TB is 21-34 times greater among people living with HIV than in the general population. In 2010, of 8.8 million incident TB cases worldwide, 1.1 million were among people living with HIV, with an estimated 350,000 deaths (WHO, 2011f). ...
Hepatitis
Preventing, Detecting and Treating Critical Co-Infections
Hepatitis is an inflammation of the liver, most often caused by a virus. The most common types of viruses are hepatitis A, hepatitis B, hepatitis C, hepatitis D and hepatitis E. "Hepatitis A and E are typically caused by ingestion of contaminated food or water and are not known to cause chronic liver disease" (WHO, 2010c). A vaccine exists for hepatitis A and a meta-analysis of eight studies fr...
Integrating CD4 count service with voluntary counseling and testing or primary health clinics can accelerate initiation of treatment.
Provision and Access
4 studies Gray I, II, IIIb CD4 count, CD4 counts, HIV testing, and Zimbabwe, health facilities, treament, treatment Cameroon, Mozambique, South Africa, Tanzania, Thailand, Uganda
Community-based antiretroviral therapy programs may be as effective for adherence as facility-based programs, with lower costs for both patients and services.
Adherence and Support
7 studies Gray I, II, IIIb adherence, community-based care, community-based programs, treatment Botswana, Brazil, Ethiopia, Guyana, Haiti, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, Peru, Rwanda, South Africa, Tanzania, Uganda, Zambia
Safe Motherhood and Prevention of Vertical Transmission
Three vital components of AIDS programming for women living with HIV are ensuring safe motherhood through access to health care before, during and after pregnancy and childbirth; ensuring access to treatment; and ensuring access to services to prevent vertical HIV transmission. While much progress has been made in reducing vertical transmission, more could be done. A recent demographic model sh...
Provision and Access
Treatment
Antiretroviral therapy has been successfully administered in a range of situations with adherence, retention, and clinical outcomes similar to those achieved in resource-rich countries. Increasing provision and access, grounded in human rights based approaches, across all populations is critical to continuing that success. "I cook scones for my children and do not get tired. I do chores, pound...
Triple therapy, when used for treatment or prophylaxis through the postpartum period reduces mother-to-child HIV transmission. [See also %{s:45}].
Postpartum
14 studies Gray I, II, IIIa, IIIb, IV, V CD4 counts, HAART, PMTCT, breastfeeding, formula feeding, treatment Botswana, Burkina Faso, Côte d’Ivoire, Ethiopia, India, Kenya, Malawi, Mozambique, Rwanda, South Africa, Southern Africa, Tanzania, Uganda
Antenatal Care - Treatment
Safe Motherhood and Prevention of Vertical Transmission
Antiretroviral treatment (ART) for women living with HIV is vital to ensuring safe motherhood and reducing vertical transmission. But not all pregnant women access treatment. For women in high-income countries where access to triple therapy during pregnancy has been the standard of care and is near universal, rates of vertical HIV transmission are as low as 0.4%, for example, in Canada (Forbes ...
(Metzger and Navaline, 2003 cited in Strathdee et al., 2006; Demaan et al., 2002 cited in Strathdee et al., 2006; Metzger et al., 2003 cited in Strathdee et al., 2006; Ball et al., 1988 cited in Strathdee et al., 2006; Bruce, 2010; Roberts et al., 2010).
Women Who Use Drugs and Female Partners of Men Who Use Drugs
10 studies Gray I, IIIa, IIIb, IV PWID, drug treatment, drug use, opioids, pregnancy, sexual partners, transmission Australia, Europe, Malaysia, Taiwan, United States
Providing treatment support and literacy, including by HIV-positive peers and by providers, can increase adherence.
Adherence and Support
4 studies Gray IIIb, V adherence, counseling, literacy, support, support groups, treatment, treatment literacy Indonesia, Mozambique, Swaziland, Thailand
Structuring Health Services to Meet Women’s Needs
The manner in which health services are structured has an impact on HIV prevention, treatment and care services for women and girls. Women often need multiple reproductive health services such as family planning in addition to HIV prevention, treatment and care, but most health care facilities are not structured to provide integrated services. Integration can be defined broadly as 1) co-locatio...
Increasing educational attainment can help reduce HIV risk among girls.
Advancing Education
12 studies Gray I, II, IIIb, IV, V HIV testing, Lao PDR, abstinence, condom use, condoms, counseling, education, income, protective behavior, risk behavior, self-perception, sex behavior, sexual behavior, sexual partners, youth Burkina Faso, Cambodia, Ethiopia, Ghana, India, Malawi, South Africa, Sub-Saharan Africa, Uganda, Zambia, Zimbabwe
Adherence and Support
Treatment
"I'm 18 years, you are telling me drugs for life?" --Woman living with HIV in Uganda (Hsieh, 2013: 11)Treatment adherence is necessary to continually suppress the virus. Adherence to ART leads to better virological outcomes, prevents disease progression and improves survival (Nachega et al., 2010a; Nachega et al., 2010c). Conversely, inadequate adherence leads to drug resistance, which can then...
Antenatal Care - Testing and Counseling
Safe Motherhood and Prevention of Vertical Transmission
In 2007, only an estimated 18% of pregnant women were offered HIV tests (ITPC, 2009). "The purpose of antenatal VCT should be to help a woman prepare for a possible positive HIV diagnosis [and] to provide her with information about PMTCT options" (De Bruyn and Paxton, 2005: 145). In developing country settings, between eight and ten percent of women report having received PMTCT interventions (P...
Meeting the Sexual and Reproductive Health Needs of Women Living With HIV
Given that most HIV transmission occurs through sexual intercourse, it is critical to include a sexual and reproductive health lens in HIV programming. In fact, several European governments have recently revised their international policies, recognizing that HIV/AIDS is a sexual and reproductive health issue (Germain et al., 2009). All women have the right to decide freely and responsibly on t...
Increasing Access to Services
Prevention and Services for Adolescents and Young People
While the literature on access to HIV services by adolescents is limited, the literature on access to sexual and reproductive health services more broadly demonstrates that youth-friendly approaches can increase use of reproductive health care services by female adolescents (Gay et al., 2015). Young peoples service needs are frequently overlooked in HIV programming that is not specifically for ...